Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0327 Transporter Info | ||||
Gene Name | SLC38A10 | ||||
Transporter Name | Putative sodium-coupled neutral amino acid transporter 10 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Hepatocellular carcinoma |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
TSS1500 (cg00774088) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.32E+00 | Statistic Test | p-value:1.23E-10; Z-score:-5.36E+00 | ||
Methylation in Case |
6.63E-01 (Median) | Methylation in Control | 8.77E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
Body (cg08034816) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.63E-02; Z-score:-1.91E-01 | ||
Methylation in Case |
7.24E-01 (Median) | Methylation in Control | 7.37E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A10 in hepatocellular carcinoma | [ 1 ] | |||
Location |
3'UTR (cg19030682) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:7.09E-05; Z-score:9.43E-01 | ||
Methylation in Case |
6.29E-01 (Median) | Methylation in Control | 5.23E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A10 in atypical teratoid rhabdoid tumor | [ 2 ] | |||
Location |
Body (cg03971338) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.74E+00 | Statistic Test | p-value:5.11E-04; Z-score:1.10E+00 | ||
Methylation in Case |
5.86E-01 (Median) | Methylation in Control | 3.36E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A10 in atypical teratoid rhabdoid tumor | [ 2 ] | |||
Location |
Body (cg05353290) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:1.39E-03; Z-score:8.33E-01 | ||
Methylation in Case |
8.32E-01 (Median) | Methylation in Control | 7.41E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A10 in atypical teratoid rhabdoid tumor | [ 2 ] | |||
Location |
Body (cg06005559) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.27E+00 | Statistic Test | p-value:2.02E-03; Z-score:1.04E+00 | ||
Methylation in Case |
6.28E-01 (Median) | Methylation in Control | 4.94E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC38A10 in atypical teratoid rhabdoid tumor | [ 2 ] | |||
Location |
Body (cg08034816) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:5.25E-03; Z-score:2.11E-01 | ||
Methylation in Case |
1.76E-01 (Median) | Methylation in Control | 1.70E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC38A10 in atypical teratoid rhabdoid tumor | [ 2 ] | |||
Location |
3'UTR (cg19030682) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:2.14E-10; Z-score:-1.57E+00 | ||
Methylation in Case |
8.57E-01 (Median) | Methylation in Control | 9.00E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg06005559) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:4.24E-04; Z-score:-4.97E+00 | ||
Methylation in Case |
8.11E-01 (Median) | Methylation in Control | 8.82E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A10 in bladder cancer | [ 3 ] | |||
Location |
Body (cg05353290) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:3.04E-02; Z-score:-8.46E-01 | ||
Methylation in Case |
8.93E-01 (Median) | Methylation in Control | 9.00E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A10 in bladder cancer | [ 3 ] | |||
Location |
3'UTR (cg19030682) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:2.21E-03; Z-score:-3.35E+00 | ||
Methylation in Case |
6.68E-01 (Median) | Methylation in Control | 7.66E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A10 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg06005559) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:1.27E-06; Z-score:-2.40E+00 | ||
Methylation in Case |
8.88E-01 (Median) | Methylation in Control | 9.23E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A10 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg24948499) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.49E+00 | Statistic Test | p-value:3.80E-05; Z-score:1.60E+00 | ||
Methylation in Case |
8.18E-01 (Median) | Methylation in Control | 5.48E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A10 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg08034816) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.16E-03; Z-score:-5.67E-01 | ||
Methylation in Case |
9.16E-01 (Median) | Methylation in Control | 9.23E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC38A10 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg03971338) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.29E+00 | Statistic Test | p-value:1.91E-03; Z-score:9.18E-01 | ||
Methylation in Case |
7.33E-01 (Median) | Methylation in Control | 5.70E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC38A10 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg22462714) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.28E+00 | Statistic Test | p-value:3.07E-02; Z-score:7.20E-01 | ||
Methylation in Case |
6.44E-01 (Median) | Methylation in Control | 5.03E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Depression |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A10 in depression | [ 5 ] | |||
Location |
Body (cg22462714) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:4.13E-02; Z-score:1.84E-01 | ||
Methylation in Case |
8.17E-01 (Median) | Methylation in Control | 8.12E-01 (Median) | ||
Studied Phenotype |
Depression[ ICD-11:6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A10 in HIV infection | [ 6 ] | |||
Location |
Body (cg22462714) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:7.25E-03; Z-score:4.68E-01 | ||
Methylation in Case |
8.97E-01 (Median) | Methylation in Control | 8.81E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A10 in HIV infection | [ 6 ] | |||
Location |
3'UTR (cg19030682) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.30E+00 | Statistic Test | p-value:8.80E-07; Z-score:-3.30E+00 | ||
Methylation in Case |
6.16E-01 (Median) | Methylation in Control | 8.01E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A10 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg22462714) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.78E-02; Z-score:-1.45E+00 | ||
Methylation in Case |
8.84E-01 (Median) | Methylation in Control | 9.05E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A10 in lung adenocarcinoma | [ 7 ] | |||
Location |
3'UTR (cg19030682) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.16E+00 | Statistic Test | p-value:1.01E-04; Z-score:-3.51E+00 | ||
Methylation in Case |
7.11E-01 (Median) | Methylation in Control | 8.28E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A10 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg19604369) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:2.97E-02; Z-score:-8.77E-02 | ||
Methylation in Case |
8.59E-01 (Median) | Methylation in Control | 8.61E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg06005559) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:9.79E-03; Z-score:-6.11E-01 | ||
Methylation in Case |
9.28E-01 (Median) | Methylation in Control | 9.37E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg03971338) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.63E-02; Z-score:-5.16E-01 | ||
Methylation in Case |
8.67E-01 (Median) | Methylation in Control | 8.73E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A10 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg08034816) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:2.70E-02; Z-score:-5.28E-01 | ||
Methylation in Case |
8.84E-01 (Median) | Methylation in Control | 8.95E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A10 in panic disorder | [ 10 ] | |||
Location |
3'UTR (cg19030682) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:2.60E-02; Z-score:3.26E-01 | ||
Methylation in Case |
2.67E+00 (Median) | Methylation in Control | 2.43E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-26b directly targets SLC38A10 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-26b | miRNA Mature ID | miR-26b-5p | ||
miRNA Sequence |
UUCAAGUAAUUCAGGAUAGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.